Key facts
- Ybrain’s last known valuation is $80.0M (Feb 2022).
- It has raised $26.4M; the latest was Later Stage VC in Dec 2024.
- Notable investors include InterVest, STIC Ventures, Mirae Asset Global Investments, Ulmus Investment, LogInvestment — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Ybrain
- ·The full record, as it builds
Funding rounds
No funding rounds for Ybrain are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ybrain
Manufacturer of a wearable medical device intended to measure and treat neuropsychiatric illnesses based on neuroscience. The company's device is a wireless EEG system that permits operators to complete the preparation and collection of EEG signals and a non-invasive brain stimulation system that uses weak currents to stimulate the human brain, enabling medical professionals to treat Major Depressive Disorder and other psychiatric illnesses.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2013
- Employees
- 55
- Website
- ybrain.com/
- Ownership
- Privately Held (backing)
Ybrain doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ybrain shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ybrain in its N-PORT filings yet. We sweep new filings monthly.